BRSK2_HUMAN - dbPTM
BRSK2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BRSK2_HUMAN
UniProt AC Q8IWQ3
Protein Name Serine/threonine-protein kinase BRSK2
Gene Name BRSK2
Organism Homo sapiens (Human).
Sequence Length 736
Subcellular Localization Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, perinuclear region. Endoplasmic reticulum. Detected at centrosomes during mitosis. Localizes to the endoplasmic reticulum in response to stress caused by tunicamycin.
Protein Description Serine/threonine-protein kinase that plays a key role in polarization of neurons and axonogenesis, cell cycle progress and insulin secretion. Phosphorylates CDK16, CDC25C, MAPT/TAU, PAK1 and WEE1. Following phosphorylation and activation by STK11/LKB1, acts as a key regulator of polarization of cortical neurons, probably by mediating phosphorylation of microtubule-associated proteins such as MAPT/TAU at 'Thr-529' and 'Ser-579'. Also regulates neuron polarization by mediating phosphorylation of WEE1 at 'Ser-642' in postmitotic neurons, leading to down-regulate WEE1 activity in polarized neurons. Plays a role in the regulation of the mitotic cell cycle progress and the onset of mitosis. Plays a role in the regulation of insulin secretion in response to elevated glucose levels, probably via phosphorylation of CDK16 and PAK1. While BRSK2 phosphorylated at Thr-174 can inhibit insulin secretion. [PubMed: 22798068), BRSK2 phosphorylated at Thr-260 can promote insulin secretion]
Protein Sequence MTSTGKDGGAQHAQYVGPYRLEKTLGKGQTGLVKLGVHCVTCQKVAIKIVNREKLSESVLMKVEREIAILKLIEHPHVLKLHDVYENKKYLYLVLEHVSGGELFDYLVKKGRLTPKEARKFFRQIISALDFCHSHSICHRDLKPENLLLDEKNNIRIADFGMASLQVGDSLLETSCGSPHYACPEVIRGEKYDGRKADVWSCGVILFALLVGALPFDDDNLRQLLEKVKRGVFHMPHFIPPDCQSLLRGMIEVDAARRLTLEHIQKHIWYIGGKNEPEPEQPIPRKVQIRSLPSLEDIDPDVLDSMHSLGCFRDRNKLLQDLLSEEENQEKMIYFLLLDRKERYPSQEDEDLPPRNEIDPPRKRVDSPMLNRHGKRRPERKSMEVLSVTDGGSPVPARRAIEMAQHGQRSRSISGASSGLSTSPLSSPRVTPHPSPRGSPLPTPKGTPVHTPKESPAGTPNPTPPSSPSVGGVPWRARLNSIKNSFLGSPRFHRRKLQVPTPEEMSNLTPESSPELAKKSWFGNFISLEKEEQIFVVIKDKPLSSIKADIVHAFLSIPSLSHSVISQTSFRAEYKATGGPAVFQKPVKFQVDITYTEGGEAQKENGIYSVTFTLLSGPSRRFKRVVETIQAQLLSTHDPPAAQHLSDTTNCMEMMTGRLSKCGSPLSNFFDVIKQLFSDEKNGQAAQAPSTPAKRSAHGPLGDSAAAGPGPGGDAEYPTGKDTAKMGPPTARREQP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8 (in isoform 5)Phosphorylation-36.5022210691
15PhosphorylationGGAQHAQYVGPYRLE
CCCCCCEEECCEEEE
14.25-
23SumoylationVGPYRLEKTLGKGQT
ECCEEEEEECCCCCC
54.35-
48UbiquitinationTCQKVAIKIVNREKL
ECCEEEEEECCHHHC
30.75-
174PhosphorylationVGDSLLETSCGSPHY
CCCHHHHCCCCCCCC
29.3214976552
178PhosphorylationLLETSCGSPHYACPE
HHHCCCCCCCCCCCH
16.90-
245PhosphorylationFIPPDCQSLLRGMIE
CCCHHHHHHHCCCHH
35.3824719451
260PhosphorylationVDAARRLTLEHIQKH
HHHHHHCCHHHHHHH
28.4316870137
291PhosphorylationPRKVQIRSLPSLEDI
CCCEEEECCCCHHHC
46.3823607784
294PhosphorylationVQIRSLPSLEDIDPD
EEEECCCCHHHCCHH
50.0829507054
344PhosphorylationLLDRKERYPSQEDED
CCCCHHHCCCCCCCC
14.3429759185
346PhosphorylationDRKERYPSQEDEDLP
CCHHHCCCCCCCCCC
36.9529759185
367PhosphorylationPPRKRVDSPMLNRHG
CCCCCCCCHHHCCCC
14.8925159151
382PhosphorylationKRRPERKSMEVLSVT
CCCCCCCCEEEEEEC
26.7925159151
387PhosphorylationRKSMEVLSVTDGGSP
CCCEEEEEECCCCCC
28.3127732954
389PhosphorylationSMEVLSVTDGGSPVP
CEEEEEECCCCCCCC
26.0829255136
393PhosphorylationLSVTDGGSPVPARRA
EEECCCCCCCCHHHH
28.4029255136
409MethylationEMAQHGQRSRSISGA
HHHHHCCCCCCCCCC
38.33-
410PhosphorylationMAQHGQRSRSISGAS
HHHHCCCCCCCCCCC
23.61-
411MethylationAQHGQRSRSISGASS
HHHCCCCCCCCCCCC
39.95-
412PhosphorylationQHGQRSRSISGASSG
HHCCCCCCCCCCCCC
23.5029978859
414PhosphorylationGQRSRSISGASSGLS
CCCCCCCCCCCCCCC
29.5629978859
416 (in isoform 4)Phosphorylation-8.1725849741
417PhosphorylationSRSISGASSGLSTSP
CCCCCCCCCCCCCCC
28.5921406692
418PhosphorylationRSISGASSGLSTSPL
CCCCCCCCCCCCCCC
43.1321406692
421PhosphorylationSGASSGLSTSPLSSP
CCCCCCCCCCCCCCC
30.2929978859
422PhosphorylationGASSGLSTSPLSSPR
CCCCCCCCCCCCCCC
39.1319958286
423PhosphorylationASSGLSTSPLSSPRV
CCCCCCCCCCCCCCC
22.0725159151
426PhosphorylationGLSTSPLSSPRVTPH
CCCCCCCCCCCCCCC
41.5029978859
427PhosphorylationLSTSPLSSPRVTPHP
CCCCCCCCCCCCCCC
25.1425159151
431PhosphorylationPLSSPRVTPHPSPRG
CCCCCCCCCCCCCCC
19.7020363803
435PhosphorylationPRVTPHPSPRGSPLP
CCCCCCCCCCCCCCC
24.9719369195
437MethylationVTPHPSPRGSPLPTP
CCCCCCCCCCCCCCC
63.66-
439PhosphorylationPHPSPRGSPLPTPKG
CCCCCCCCCCCCCCC
25.2520363803
443PhosphorylationPRGSPLPTPKGTPVH
CCCCCCCCCCCCCCC
45.3620363803
443 (in isoform 4)Phosphorylation-45.3625159151
444 (in isoform 4)Phosphorylation-31.0125159151
445 (in isoform 4)Phosphorylation-77.2925159151
447PhosphorylationPLPTPKGTPVHTPKE
CCCCCCCCCCCCCCC
28.4127732954
451PhosphorylationPKGTPVHTPKESPAG
CCCCCCCCCCCCCCC
35.9728985074
455PhosphorylationPVHTPKESPAGTPNP
CCCCCCCCCCCCCCC
26.6127732954
459PhosphorylationPKESPAGTPNPTPPS
CCCCCCCCCCCCCCC
23.2327251275
463PhosphorylationPAGTPNPTPPSSPSV
CCCCCCCCCCCCCCC
55.2428985074
466PhosphorylationTPNPTPPSSPSVGGV
CCCCCCCCCCCCCCC
56.9627732954
467PhosphorylationPNPTPPSSPSVGGVP
CCCCCCCCCCCCCCC
27.2827050516
469PhosphorylationPTPPSSPSVGGVPWR
CCCCCCCCCCCCCHH
35.0327732954
481PhosphorylationPWRARLNSIKNSFLG
CHHHHHHHHHHHCCC
39.2628464451
485PhosphorylationRLNSIKNSFLGSPRF
HHHHHHHHCCCCCCH
19.4929396449
489PhosphorylationIKNSFLGSPRFHRRK
HHHHCCCCCCHHCCC
18.3022167270
501PhosphorylationRRKLQVPTPEEMSNL
CCCCCCCCHHHHHCC
44.4627732954
506PhosphorylationVPTPEEMSNLTPESS
CCCHHHHHCCCCCCC
31.7820363803
509PhosphorylationPEEMSNLTPESSPEL
HHHHHCCCCCCCHHH
29.3025159151
512PhosphorylationMSNLTPESSPELAKK
HHCCCCCCCHHHHHH
53.0125159151
513PhosphorylationSNLTPESSPELAKKS
HCCCCCCCHHHHHHH
22.2625159151
520O-linked_GlycosylationSPELAKKSWFGNFIS
CHHHHHHHCCCCCCC
27.2530379171
520PhosphorylationSPELAKKSWFGNFIS
CHHHHHHHCCCCCCC
27.2529507054
544PhosphorylationVIKDKPLSSIKADIV
EECCCCHHHCCHHHH
38.2524719451
608PhosphorylationAQKENGIYSVTFTLL
HEHHCCEEEEEEEEE
9.8528509920
609PhosphorylationQKENGIYSVTFTLLS
EHHCCEEEEEEEEEC
16.8628509920
611PhosphorylationENGIYSVTFTLLSGP
HCCEEEEEEEEECCC
12.6428509920
613 (in isoform 6)Phosphorylation-19.8828985074
613PhosphorylationGIYSVTFTLLSGPSR
CEEEEEEEEECCCCH
19.8828509920
664PhosphorylationGRLSKCGSPLSNFFD
CCHHHCCCCHHHHHH
31.9427050516
673 (in isoform 2)Phosphorylation-2.2428985074
690PhosphorylationGQAAQAPSTPAKRSA
CCCCCCCCCCCCCCC
50.4630631047
695 (in isoform 4)Phosphorylation-40.9828985074

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
174TPhosphorylationKinaseSTK11Q15831
PhosphoELM
260TPhosphorylationKinasePRKACAP17612
GPS
260TPhosphorylationKinasePKA-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
174TPhosphorylation

14976552
174TPhosphorylation

14976552
174TPhosphorylation

14976552
260TPhosphorylation

16870137
260TPhosphorylation

16870137
260TPhosphorylation

16870137

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BRSK2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
WEE1_HUMANWEE1physical
15150265
MPIP2_HUMANCDC25Bphysical
15150265
MPIP3_HUMANCDC25Cphysical
15150265
TERA_HUMANVCPphysical
23907667
CSN5_HUMANCOPS5physical
22609399

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BRSK2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-382; SER-393; SER-412AND THR-509, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294; SER-367; SER-382;THR-389; SER-393; THR-422; SER-423; SER-427; SER-435 AND SER-466,PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-416 (ISOFORM 4), ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-382; SER-393 ANDSER-423, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-489, AND MASSSPECTROMETRY.
"Investigating the regulation of brain-specific kinases 1 and 2 byphosphorylation.";
Bright N.J., Carling D., Thornton C.;
J. Biol. Chem. 283:14946-14954(2008).
Cited for: PHOSPHORYLATION AT THR-174, AND MUTAGENESIS OF THR-174 AND GLY-310.
"LKB1 is a master kinase that activates 13 kinases of the AMPKsubfamily, including MARK/PAR-1.";
Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,Alessi D.R.;
EMBO J. 23:833-843(2004).
Cited for: FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT THR-174, ANDMUTAGENESIS OF THR-174.

TOP